Brophy v. Jiangbo Pharmaceuticals, 781 F.3d 1295 (11th Cir. 2015)
Affirming order of dismissal for failure to meet heightened pleading requirement of the Private Securities Litigation Reform Act, in Chinese Pharma Class Action litigation.
Affirming order of dismissal for failure to meet heightened pleading requirement of the Private Securities Litigation Reform Act, in Chinese Pharma Class Action litigation.